Review



pld2 inhibitor cay10594  (Cayman Chemical)


Bioz Verified Symbol Cayman Chemical is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Cayman Chemical pld2 inhibitor cay10594
    Pld2 Inhibitor Cay10594, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cay10594/pld1+inhibitor+vu0155069/pm37691020-68-24-28
    Average 90 stars, based on 1 article reviews
    pld2 inhibitor cay10594 - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Recombinant:

    Article Title: Mono- and Poly-unsaturated Phosphatidic Acid Regulate Distinct Steps of Regulated Exocytosis in Neuroendocrine Cells.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti-CgA Home made (Chasserot-Golaz et al., 1996) Anti-PLD1 Cell Signaling Cat# 3832; RRID:AB_2172256 Anti-PLD2 Cell Signaling Cat# 13904; RRID:AB_2798341 HRP-conjugated anti-mouse and anti-rabbit PerBio Cat# 31430; RRID:AB_228307, 31460; RRID:AB_228341 Anti-SNAP-25 Covance Cat# SMI-81; RRID:AB_2315336 Anti-GFP Abcam Cat# ab290; RRID:AB_303395 Gold particle-conjugated anti-rabbit Aurion N/A Chemicals, Peptides, and Recombinant Proteins FIPI Cayman Chemicals Cat# 13563 CAY10593 Cayman Chemicals Cat# 13206 CAY10594 Cayman Chemicals Cat# 13207 Lipofectamine 2000 Thermo Scientific Cat# 11668019 1-stearoyl-2-oleoyl-sn-glycero-3-phosphate PA(36:1) Avanti Polar Lipids Cat# 840861C 1-stearoyl-2-linoleoyl-sn-glycero-3-phosphate PA(36:2) Avanti Polar Lipids Cat# 840862C 1-stearoyl-2-docosahexaenoyl-sn-glycero-3-phosphate PA(40:6) Avanti Polar Lipids Cat# 840864C 1,2-didocosahexaenoyl-sn-glycero-3-phosphate PA(44:12) Avanti Polar Lipids Cat# 840887C L-a-phosphatidic acid (Egg, Chicken) PA mix Avanti Polar Lipids Cat# 840101C Hexamethyldisilazane Sigma Aldrich Cat# 440191 Critical Commercial Assays 3-CAT research ELISA kit Eurobio BA E-5600 Basic Primary Neurons Nucleofector Kit Lonza VVPI-1003 Experimental Models: Cell Lines PC12 Laurent Taupenot (Taupenot et al., 1998) Experimental Models: Organisms/Strains Mouse Pld1 / Bernard Nieswandt (Elvers et al., 2010) Mouse Pld2 / Gilbert Di Paolo (Oliveira et al., 2010) Recombinant DNA Spo20p-GFP N/A (Kassas et al., 2017) PDE4A1-GFP N/A (Kassas et al., 2017) Software and Algorithms Adobe Photoshop Adobe https://www.adobe.com SigmaPlot 13 Systat Software https://systatsoftware.com Igor Pro WaveMetrics http://www.wavemetrics.com/ Macro for amperometry analysis Ricardo Borges http://rborges.webs.ull.es/ Icy BioImage Analysis Lab, Institut Pasteur http://icy.bioimageanalysis.org/ Other Carbon-fiber electrode of 5 mm diameter ALA Scientific CFE-2 e1 Cell Reports 32, 108026, August 18, 2020 ..

    Enzyme-linked Immunosorbent Assay:

    Article Title: Mono- and Poly-unsaturated Phosphatidic Acid Regulate Distinct Steps of Regulated Exocytosis in Neuroendocrine Cells.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti-CgA Home made (Chasserot-Golaz et al., 1996) Anti-PLD1 Cell Signaling Cat# 3832; RRID:AB_2172256 Anti-PLD2 Cell Signaling Cat# 13904; RRID:AB_2798341 HRP-conjugated anti-mouse and anti-rabbit PerBio Cat# 31430; RRID:AB_228307, 31460; RRID:AB_228341 Anti-SNAP-25 Covance Cat# SMI-81; RRID:AB_2315336 Anti-GFP Abcam Cat# ab290; RRID:AB_303395 Gold particle-conjugated anti-rabbit Aurion N/A Chemicals, Peptides, and Recombinant Proteins FIPI Cayman Chemicals Cat# 13563 CAY10593 Cayman Chemicals Cat# 13206 CAY10594 Cayman Chemicals Cat# 13207 Lipofectamine 2000 Thermo Scientific Cat# 11668019 1-stearoyl-2-oleoyl-sn-glycero-3-phosphate PA(36:1) Avanti Polar Lipids Cat# 840861C 1-stearoyl-2-linoleoyl-sn-glycero-3-phosphate PA(36:2) Avanti Polar Lipids Cat# 840862C 1-stearoyl-2-docosahexaenoyl-sn-glycero-3-phosphate PA(40:6) Avanti Polar Lipids Cat# 840864C 1,2-didocosahexaenoyl-sn-glycero-3-phosphate PA(44:12) Avanti Polar Lipids Cat# 840887C L-a-phosphatidic acid (Egg, Chicken) PA mix Avanti Polar Lipids Cat# 840101C Hexamethyldisilazane Sigma Aldrich Cat# 440191 Critical Commercial Assays 3-CAT research ELISA kit Eurobio BA E-5600 Basic Primary Neurons Nucleofector Kit Lonza VVPI-1003 Experimental Models: Cell Lines PC12 Laurent Taupenot (Taupenot et al., 1998) Experimental Models: Organisms/Strains Mouse Pld1 / Bernard Nieswandt (Elvers et al., 2010) Mouse Pld2 / Gilbert Di Paolo (Oliveira et al., 2010) Recombinant DNA Spo20p-GFP N/A (Kassas et al., 2017) PDE4A1-GFP N/A (Kassas et al., 2017) Software and Algorithms Adobe Photoshop Adobe https://www.adobe.com SigmaPlot 13 Systat Software https://systatsoftware.com Igor Pro WaveMetrics http://www.wavemetrics.com/ Macro for amperometry analysis Ricardo Borges http://rborges.webs.ull.es/ Icy BioImage Analysis Lab, Institut Pasteur http://icy.bioimageanalysis.org/ Other Carbon-fiber electrode of 5 mm diameter ALA Scientific CFE-2 e1 Cell Reports 32, 108026, August 18, 2020 ..

    Software:

    Article Title: Mono- and Poly-unsaturated Phosphatidic Acid Regulate Distinct Steps of Regulated Exocytosis in Neuroendocrine Cells.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Anti-CgA Home made (Chasserot-Golaz et al., 1996) Anti-PLD1 Cell Signaling Cat# 3832; RRID:AB_2172256 Anti-PLD2 Cell Signaling Cat# 13904; RRID:AB_2798341 HRP-conjugated anti-mouse and anti-rabbit PerBio Cat# 31430; RRID:AB_228307, 31460; RRID:AB_228341 Anti-SNAP-25 Covance Cat# SMI-81; RRID:AB_2315336 Anti-GFP Abcam Cat# ab290; RRID:AB_303395 Gold particle-conjugated anti-rabbit Aurion N/A Chemicals, Peptides, and Recombinant Proteins FIPI Cayman Chemicals Cat# 13563 CAY10593 Cayman Chemicals Cat# 13206 CAY10594 Cayman Chemicals Cat# 13207 Lipofectamine 2000 Thermo Scientific Cat# 11668019 1-stearoyl-2-oleoyl-sn-glycero-3-phosphate PA(36:1) Avanti Polar Lipids Cat# 840861C 1-stearoyl-2-linoleoyl-sn-glycero-3-phosphate PA(36:2) Avanti Polar Lipids Cat# 840862C 1-stearoyl-2-docosahexaenoyl-sn-glycero-3-phosphate PA(40:6) Avanti Polar Lipids Cat# 840864C 1,2-didocosahexaenoyl-sn-glycero-3-phosphate PA(44:12) Avanti Polar Lipids Cat# 840887C L-a-phosphatidic acid (Egg, Chicken) PA mix Avanti Polar Lipids Cat# 840101C Hexamethyldisilazane Sigma Aldrich Cat# 440191 Critical Commercial Assays 3-CAT research ELISA kit Eurobio BA E-5600 Basic Primary Neurons Nucleofector Kit Lonza VVPI-1003 Experimental Models: Cell Lines PC12 Laurent Taupenot (Taupenot et al., 1998) Experimental Models: Organisms/Strains Mouse Pld1 / Bernard Nieswandt (Elvers et al., 2010) Mouse Pld2 / Gilbert Di Paolo (Oliveira et al., 2010) Recombinant DNA Spo20p-GFP N/A (Kassas et al., 2017) PDE4A1-GFP N/A (Kassas et al., 2017) Software and Algorithms Adobe Photoshop Adobe https://www.adobe.com SigmaPlot 13 Systat Software https://systatsoftware.com Igor Pro WaveMetrics http://www.wavemetrics.com/ Macro for amperometry analysis Ricardo Borges http://rborges.webs.ull.es/ Icy BioImage Analysis Lab, Institut Pasteur http://icy.bioimageanalysis.org/ Other Carbon-fiber electrode of 5 mm diameter ALA Scientific CFE-2 e1 Cell Reports 32, 108026, August 18, 2020 ..

    Control:

    Article Title: Deletion of PLD2 Alleviates LPS Induced Acute Lung Injury by Inhibiting STAT3 Phosphorylation and Regulating Endothelial Tight Junctions
    Article Snippet: Cells were cultured to 85–90% con uency and passaged in 0.25% trypsin (containing 0.02% EDTA; Procell, Wuhan, China). .. The cells were also separated into four groups: control, LPS (10μg/ml), LPS + CAY10594 (PLD2 inhibitor) (10μmol/L; 1130067-34-3, Page 5/22 Cayman chemical, Michigan, USA), and CAY10594 group. .. In the experiment of adding exogenous PA, HUVECs were divided into four groups: control, PA (50μmol/L), PA + STAT3-IN-1 (STAT3 inhibitor) (5uM; Cat. No.Hy-100753, MedChemExpress, Shanghai, China), and STAT3-IN-1 group.



    Similar Products

    93
    MedChemExpress cay10594 powder
    Cay10594 Powder, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cay10594/CAY10594/pm41110487-32-7-13
    Average 93 stars, based on 1 article reviews
    cay10594 powder - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    90
    TargetMol cay10594
    Figure 6. D-AS2 promotes PLD/PA-mediated YAP activation. A, Western blot analyses of YAP and LATS1 phosphorylation. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or <t>CAY10594</t> (20 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. B, qRT-PCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; n ¼ 3 technical replicates. C and D, IF detection of YAP localization in KYSE450 cells expressing EV or D-AS2. Cells were pre- treated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L). YAP localization is shown in C. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean SEM values. E, Western blot analyses of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2–target- ing sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. F, qRT-PCR detection of the YAP target genes CTGF and CYR61. Serum- starved KYSE30 cells expressing control or D-AS2–targeting sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; ns, not significant; n ¼ 3 technical replicates. G and H, IF detection of YAP localization in KYSE30 cells expressing control and D-AS2–targeting sgRNAs and pretreated with PA (100 mmol/L) for 1 hour. YAP local- ization is shown in G. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localiza- tion (H). The data are expressed as the mean SEM values. I, qRT-PCR detection of the expression of the indicated genes in the samples with chemoresistance or chemosensitivity of patients with esoph- ageal SCC. The data are presented as the mean SEM values; two-tailed t test; n ¼ 17 for chemoresistant patients; n ¼ 17 for chemosensitive patients.
    Cay10594, supplied by TargetMol, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cay10594/CAY10594/10__1158_slash_0008___5472__can___22___0717-94-3-8
    Average 90 stars, based on 1 article reviews
    cay10594 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    92
    Santa Cruz Biotechnology cay10594
    Figure 6. D-AS2 promotes PLD/PA-mediated YAP activation. A, Western blot analyses of YAP and LATS1 phosphorylation. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or <t>CAY10594</t> (20 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. B, qRT-PCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; n ¼ 3 technical replicates. C and D, IF detection of YAP localization in KYSE450 cells expressing EV or D-AS2. Cells were pre- treated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L). YAP localization is shown in C. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean SEM values. E, Western blot analyses of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2–target- ing sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. F, qRT-PCR detection of the YAP target genes CTGF and CYR61. Serum- starved KYSE30 cells expressing control or D-AS2–targeting sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; ns, not significant; n ¼ 3 technical replicates. G and H, IF detection of YAP localization in KYSE30 cells expressing control and D-AS2–targeting sgRNAs and pretreated with PA (100 mmol/L) for 1 hour. YAP local- ization is shown in G. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localiza- tion (H). The data are expressed as the mean SEM values. I, qRT-PCR detection of the expression of the indicated genes in the samples with chemoresistance or chemosensitivity of patients with esoph- ageal SCC. The data are presented as the mean SEM values; two-tailed t test; n ¼ 17 for chemoresistant patients; n ¼ 17 for chemosensitive patients.
    Cay10594, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cay10594/CAY10594/pm40499840-122-175-176
    Average 92 stars, based on 1 article reviews
    cay10594 - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    90
    Millipore cay10594
    Figure 6. D-AS2 promotes PLD/PA-mediated YAP activation. A, Western blot analyses of YAP and LATS1 phosphorylation. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or <t>CAY10594</t> (20 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. B, qRT-PCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; n ¼ 3 technical replicates. C and D, IF detection of YAP localization in KYSE450 cells expressing EV or D-AS2. Cells were pre- treated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L). YAP localization is shown in C. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean SEM values. E, Western blot analyses of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2–target- ing sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. F, qRT-PCR detection of the YAP target genes CTGF and CYR61. Serum- starved KYSE30 cells expressing control or D-AS2–targeting sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; ns, not significant; n ¼ 3 technical replicates. G and H, IF detection of YAP localization in KYSE30 cells expressing control and D-AS2–targeting sgRNAs and pretreated with PA (100 mmol/L) for 1 hour. YAP local- ization is shown in G. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localiza- tion (H). The data are expressed as the mean SEM values. I, qRT-PCR detection of the expression of the indicated genes in the samples with chemoresistance or chemosensitivity of patients with esoph- ageal SCC. The data are presented as the mean SEM values; two-tailed t test; n ¼ 17 for chemoresistant patients; n ¼ 17 for chemosensitive patients.
    Cay10594, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cay10594/cay10594/pm38703555-46-3-15
    Average 90 stars, based on 1 article reviews
    cay10594 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Cayman Chemical pld2 inhibitor cay10594
    Figure 6. D-AS2 promotes PLD/PA-mediated YAP activation. A, Western blot analyses of YAP and LATS1 phosphorylation. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or <t>CAY10594</t> (20 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. B, qRT-PCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; n ¼ 3 technical replicates. C and D, IF detection of YAP localization in KYSE450 cells expressing EV or D-AS2. Cells were pre- treated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L). YAP localization is shown in C. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean SEM values. E, Western blot analyses of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2–target- ing sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. F, qRT-PCR detection of the YAP target genes CTGF and CYR61. Serum- starved KYSE30 cells expressing control or D-AS2–targeting sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; ns, not significant; n ¼ 3 technical replicates. G and H, IF detection of YAP localization in KYSE30 cells expressing control and D-AS2–targeting sgRNAs and pretreated with PA (100 mmol/L) for 1 hour. YAP local- ization is shown in G. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localiza- tion (H). The data are expressed as the mean SEM values. I, qRT-PCR detection of the expression of the indicated genes in the samples with chemoresistance or chemosensitivity of patients with esoph- ageal SCC. The data are presented as the mean SEM values; two-tailed t test; n ¼ 17 for chemoresistant patients; n ¼ 17 for chemosensitive patients.
    Pld2 Inhibitor Cay10594, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cay10594/pld1+inhibitor+vu0155069/pm37691020-68-24-28
    Average 90 stars, based on 1 article reviews
    pld2 inhibitor cay10594 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Cayman Chemical cay10594
    Figure 6. D-AS2 promotes PLD/PA-mediated YAP activation. A, Western blot analyses of YAP and LATS1 phosphorylation. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or <t>CAY10594</t> (20 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. B, qRT-PCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; n ¼ 3 technical replicates. C and D, IF detection of YAP localization in KYSE450 cells expressing EV or D-AS2. Cells were pre- treated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L). YAP localization is shown in C. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean SEM values. E, Western blot analyses of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2–target- ing sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. F, qRT-PCR detection of the YAP target genes CTGF and CYR61. Serum- starved KYSE30 cells expressing control or D-AS2–targeting sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; ns, not significant; n ¼ 3 technical replicates. G and H, IF detection of YAP localization in KYSE30 cells expressing control and D-AS2–targeting sgRNAs and pretreated with PA (100 mmol/L) for 1 hour. YAP local- ization is shown in G. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localiza- tion (H). The data are expressed as the mean SEM values. I, qRT-PCR detection of the expression of the indicated genes in the samples with chemoresistance or chemosensitivity of patients with esoph- ageal SCC. The data are presented as the mean SEM values; two-tailed t test; n ¼ 17 for chemoresistant patients; n ¼ 17 for chemosensitive patients.
    Cay10594, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cay10594/cay10598/ppr0504770-67-25-20
    Average 90 stars, based on 1 article reviews
    cay10594 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Topscience Co Ltd cay10594 (1130067-34-3)
    ( A ) IB detection of YAP and LATS1 phosphorylation. KYSE450 cells expressing empty vector (EV) and D-AS2 were pretreated with FIPI (30 µM) or <t>CAY10594</t> (20 µM) for 1 h. ( B ) RT-qPCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV and D-AS2 were pretreated with FIPI (30 µM) or CAY10594 (20 µM) for 1 h. The data are presented as the mean ± s.d. values; two-tailed t test, *** P < 0.001; n = 3. ( C, D ) IF detection of YAP localization in KYSE450 cells expressing EV and D-AS2. Cells were pretreated with FIPI (30 µM) or CAY10594 (20 µM). YAP localization is shown in (C); scale bar, 30 µm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean ± s.e.m. values. ( E ) IB detection of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2-targeting sgRNAs were pretreated with PA (100 µM) for 1 h. ( F ) RT-qPCR detection of the YAP target genes CTGF and CYR61. Serum-starved KYSE30 cells expressing control or D-AS2-targeting sgRNAs were pretreated with PA (100 µM) for 1 h. The data are presented as the mean ± s.d. values; two-tailed t test, *** P < 0.001, ns: not significant; n = 3. ( G, H ) IF detection of YAP localization in KYSE30 cells expressing control and D-AS2-targeting sgRNAs and pretreated with PA (100 µM) for 1 h. YAP localization is shown in (G); scale bar, 30 µm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (H). The data are expressed as the mean ± s.e.m. values. ( I ) RT-qPCR detection of the indicated genes expression in the samples with chemoresistance or chemosensitivity of esophageal SCC patients. The data are presented as the mean ± s.e.m. values; two-tailed t test; n = 17 for chemoresistant patients; n = 17 for chemosensitive patients.
    Cay10594 (1130067 34 3), supplied by Topscience Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cay10594/cay10594++1130067+34+3+/bio_rxiv__2022__02__24__481869-70-3-8
    Average 90 stars, based on 1 article reviews
    cay10594 (1130067-34-3) - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    92
    Santa Cruz Biotechnology cay10594 inhibitor
    ( A ) IB detection of YAP and LATS1 phosphorylation. KYSE450 cells expressing empty vector (EV) and D-AS2 were pretreated with FIPI (30 µM) or <t>CAY10594</t> (20 µM) for 1 h. ( B ) RT-qPCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV and D-AS2 were pretreated with FIPI (30 µM) or CAY10594 (20 µM) for 1 h. The data are presented as the mean ± s.d. values; two-tailed t test, *** P < 0.001; n = 3. ( C, D ) IF detection of YAP localization in KYSE450 cells expressing EV and D-AS2. Cells were pretreated with FIPI (30 µM) or CAY10594 (20 µM). YAP localization is shown in (C); scale bar, 30 µm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean ± s.e.m. values. ( E ) IB detection of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2-targeting sgRNAs were pretreated with PA (100 µM) for 1 h. ( F ) RT-qPCR detection of the YAP target genes CTGF and CYR61. Serum-starved KYSE30 cells expressing control or D-AS2-targeting sgRNAs were pretreated with PA (100 µM) for 1 h. The data are presented as the mean ± s.d. values; two-tailed t test, *** P < 0.001, ns: not significant; n = 3. ( G, H ) IF detection of YAP localization in KYSE30 cells expressing control and D-AS2-targeting sgRNAs and pretreated with PA (100 µM) for 1 h. YAP localization is shown in (G); scale bar, 30 µm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (H). The data are expressed as the mean ± s.e.m. values. ( I ) RT-qPCR detection of the indicated genes expression in the samples with chemoresistance or chemosensitivity of esophageal SCC patients. The data are presented as the mean ± s.e.m. values; two-tailed t test; n = 17 for chemoresistant patients; n = 17 for chemosensitive patients.
    Cay10594 Inhibitor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cay10594/CAY10594/pm33343836-147-1-10
    Average 92 stars, based on 1 article reviews
    cay10594 inhibitor - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    Image Search Results


    Figure 6. D-AS2 promotes PLD/PA-mediated YAP activation. A, Western blot analyses of YAP and LATS1 phosphorylation. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. B, qRT-PCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; n ¼ 3 technical replicates. C and D, IF detection of YAP localization in KYSE450 cells expressing EV or D-AS2. Cells were pre- treated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L). YAP localization is shown in C. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean SEM values. E, Western blot analyses of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2–target- ing sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. F, qRT-PCR detection of the YAP target genes CTGF and CYR61. Serum- starved KYSE30 cells expressing control or D-AS2–targeting sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; ns, not significant; n ¼ 3 technical replicates. G and H, IF detection of YAP localization in KYSE30 cells expressing control and D-AS2–targeting sgRNAs and pretreated with PA (100 mmol/L) for 1 hour. YAP local- ization is shown in G. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localiza- tion (H). The data are expressed as the mean SEM values. I, qRT-PCR detection of the expression of the indicated genes in the samples with chemoresistance or chemosensitivity of patients with esoph- ageal SCC. The data are presented as the mean SEM values; two-tailed t test; n ¼ 17 for chemoresistant patients; n ¼ 17 for chemosensitive patients.

    Journal: Cancer Research

    Article Title: DLGAP1-AS2–Mediated Phosphatidic Acid Synthesis Activates YAP Signaling and Confers Chemoresistance in Squamous Cell Carcinoma

    doi: 10.1158/0008-5472.can-22-0717

    Figure Lengend Snippet: Figure 6. D-AS2 promotes PLD/PA-mediated YAP activation. A, Western blot analyses of YAP and LATS1 phosphorylation. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. B, qRT-PCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV or D-AS2 were pretreated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; n ¼ 3 technical replicates. C and D, IF detection of YAP localization in KYSE450 cells expressing EV or D-AS2. Cells were pre- treated with FIPI (30 mmol/L) or CAY10594 (20 mmol/L). YAP localization is shown in C. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean SEM values. E, Western blot analyses of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2–target- ing sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. Representative results of at least three biological replicates are shown. F, qRT-PCR detection of the YAP target genes CTGF and CYR61. Serum- starved KYSE30 cells expressing control or D-AS2–targeting sgRNAs were pretreated with PA (100 mmol/L) for 1 hour. The data are presented as the mean SD values; two-tailed t test; , P < 0.001; ns, not significant; n ¼ 3 technical replicates. G and H, IF detection of YAP localization in KYSE30 cells expressing control and D-AS2–targeting sgRNAs and pretreated with PA (100 mmol/L) for 1 hour. YAP local- ization is shown in G. Scale bar, 30 mm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localiza- tion (H). The data are expressed as the mean SEM values. I, qRT-PCR detection of the expression of the indicated genes in the samples with chemoresistance or chemosensitivity of patients with esoph- ageal SCC. The data are presented as the mean SEM values; two-tailed t test; n ¼ 17 for chemoresistant patients; n ¼ 17 for chemosensitive patients.

    Article Snippet: FIPI (939055-18-2) and CAY10594 (1130067-34-3) were purchased from Topscience.

    Techniques: Activation Assay, Western Blot, Phospho-proteomics, Expressing, Quantitative RT-PCR, Two Tailed Test, Control

    ( A ) IB detection of YAP and LATS1 phosphorylation. KYSE450 cells expressing empty vector (EV) and D-AS2 were pretreated with FIPI (30 µM) or CAY10594 (20 µM) for 1 h. ( B ) RT-qPCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV and D-AS2 were pretreated with FIPI (30 µM) or CAY10594 (20 µM) for 1 h. The data are presented as the mean ± s.d. values; two-tailed t test, *** P < 0.001; n = 3. ( C, D ) IF detection of YAP localization in KYSE450 cells expressing EV and D-AS2. Cells were pretreated with FIPI (30 µM) or CAY10594 (20 µM). YAP localization is shown in (C); scale bar, 30 µm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean ± s.e.m. values. ( E ) IB detection of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2-targeting sgRNAs were pretreated with PA (100 µM) for 1 h. ( F ) RT-qPCR detection of the YAP target genes CTGF and CYR61. Serum-starved KYSE30 cells expressing control or D-AS2-targeting sgRNAs were pretreated with PA (100 µM) for 1 h. The data are presented as the mean ± s.d. values; two-tailed t test, *** P < 0.001, ns: not significant; n = 3. ( G, H ) IF detection of YAP localization in KYSE30 cells expressing control and D-AS2-targeting sgRNAs and pretreated with PA (100 µM) for 1 h. YAP localization is shown in (G); scale bar, 30 µm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (H). The data are expressed as the mean ± s.e.m. values. ( I ) RT-qPCR detection of the indicated genes expression in the samples with chemoresistance or chemosensitivity of esophageal SCC patients. The data are presented as the mean ± s.e.m. values; two-tailed t test; n = 17 for chemoresistant patients; n = 17 for chemosensitive patients.

    Journal: bioRxiv

    Article Title: DLGAP1-AS2-Mediated Phosphatidic Acid Synthesis Confers Chemoresistance via Activation of YAP Signaling

    doi: 10.1101/2022.02.24.481869

    Figure Lengend Snippet: ( A ) IB detection of YAP and LATS1 phosphorylation. KYSE450 cells expressing empty vector (EV) and D-AS2 were pretreated with FIPI (30 µM) or CAY10594 (20 µM) for 1 h. ( B ) RT-qPCR detection of the YAP target genes CTGF and CYR61. KYSE450 cells expressing EV and D-AS2 were pretreated with FIPI (30 µM) or CAY10594 (20 µM) for 1 h. The data are presented as the mean ± s.d. values; two-tailed t test, *** P < 0.001; n = 3. ( C, D ) IF detection of YAP localization in KYSE450 cells expressing EV and D-AS2. Cells were pretreated with FIPI (30 µM) or CAY10594 (20 µM). YAP localization is shown in (C); scale bar, 30 µm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (D). The data are expressed as the mean ± s.e.m. values. ( E ) IB detection of YAP and LATS1 phosphorylation. Serum-starved KYSE30 cells expressing control or D-AS2-targeting sgRNAs were pretreated with PA (100 µM) for 1 h. ( F ) RT-qPCR detection of the YAP target genes CTGF and CYR61. Serum-starved KYSE30 cells expressing control or D-AS2-targeting sgRNAs were pretreated with PA (100 µM) for 1 h. The data are presented as the mean ± s.d. values; two-tailed t test, *** P < 0.001, ns: not significant; n = 3. ( G, H ) IF detection of YAP localization in KYSE30 cells expressing control and D-AS2-targeting sgRNAs and pretreated with PA (100 µM) for 1 h. YAP localization is shown in (G); scale bar, 30 µm. Cells from three different fields in three independent experiments were randomly selected for quantification of YAP localization (H). The data are expressed as the mean ± s.e.m. values. ( I ) RT-qPCR detection of the indicated genes expression in the samples with chemoresistance or chemosensitivity of esophageal SCC patients. The data are presented as the mean ± s.e.m. values; two-tailed t test; n = 17 for chemoresistant patients; n = 17 for chemosensitive patients.

    Article Snippet: FIPI (939055-18-2) and CAY10594 (1130067-34-3) were purchased from Topscience (Topscience; Shanghai, China).

    Techniques: Expressing, Plasmid Preparation, Quantitative RT-PCR, Two Tailed Test